Phase 3 Readout~month

Phase 3 Topline: A Phase 3 Study of NBTXR3 Activated by Investigator's Choice of Radiotherapy Alone or Radiotherapy i

Drug
nbtxr3
Indication
Carcinoma, Squamous Cell

Other upcoming events for JNJ

Phase 3 ReadoutPhase 3 Topline: Bumetanide vs. Furosemide for Adults Hospitalized With Cirrhosis: the BUFF Trial
Phase 3 ReadoutPhase 3 Topline: Bumetanide vs. Furosemide for Adults Hospitalized With Cirrhosis: the BUFF Trial

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 3 Study of NBTXR3 Activated by Investigator's Choice of Radiotherapy Alone or Radiotherapy i — JNJ Phase 3 Readout | BioSniper